POKO Innovations an award-winning UK-based collection of CBD-focused companies that bring innovative, inspiring solutions to the CBD industry through the company’s leading platforms which, when working together, form a complete ecosystem, is pleased to announce today that it has received validation and authorization from the UK Food Standard Agency (FSA) under the Novel Food Application for 44 CBD products to be sold in the UK – any product not on the FSA approved list must be removed from sale.
The list was first published in April, 2021 and is updated periodically. Among the 44 approved CBD products are POKO Gummies, Oral Sprays, CBD C Coffee and Teas, Capsules and Tinctures; these 44 CBD products are listed under POKO subsidiaries Candid and Canmed Brands. POKO CBD Pouches were also approved.
“This is one of the most important events in the history of our young company and it enables Poko Innovations to complete discussions and negotiations with large retailers and wholesalers in the UK, Ireland and the EU,” said POKO CEO David Hughes.
“Up to this point in time we have been selling our products in test markets very successfully, and now, with this approval, we can approach any retailer or wholesaler in the UK,” said POKO COO Justine O’ Hanlon.
The company has also launched its Rob Kearney and Jess Redden social media campaign ahead the launch of its Rob Kearny-endorsed daily SPF 50 moisturizer.
Novel Foods are ingredients which have not been widely consumed by people in the UK or European Union before May 1997. With the FSA approval POKO can now aggressively market its products in the UK, Ireland and the EU.
According to industry data the CBD market in the UK comprises 8 percent of the adult population, representing sales of more than $250 million dollars and should be valued at $1.3 billion by 2025.
